Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 20.73 | 24.91 |
| PEG Ratio (TTM) | -0.37 | -0.41 |
| P/S Ratio (TTM) | 0.57 | 1.74 |
| P/B Ratio (TTM) | 9.48 | 2.21 |
| P/FCF Ratio (TTM) | 10.56 | 8.56 |
| Price to 5YR AVG Earnings Ratio | 6.63 | 11.01 |
| Price to 5YR AVG FCF Ratio | 9.91 | 10.53 |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.93% | 4.91% |
| ROE (TTM) | 37.02% | 16.22% |
| Net Profit Margin (TTM) | 2.77% | -26.40% |
| ROIC 5YR AVG | 46.49% | 21.45% |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 52.32% | 69.17% | 41.94% |
| Revenue | -8.99% | 14.08% | 15.35% |
| Net Income | 50.17% | 59.97% | 34.96% |
| Cash Flow | -16.84% | 17.15% | 33.06% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.32 | 2.09 |
| Quick Ratio (TTM) | 0.37 | 0.89 |
| D/E Ratio (TTM) | 5.25 | 0.84 |
| Interest Coverage (TTM) | 4.58 | 1.30 |
| Piotroski F-Score | 8 | 7 |
| Altman Z-Score | 2.27 | 3.52 |
| LTL to 5YR AVG FCF | 7.25 | 4.95 |
| Shares Outstanding Growth 5YR AVG | -4.72% | -1.89% |